Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Siemens Healthineers AG's Ending Cash Position for the quarter that ended in Jun. 2026 was €2,360 Mil.
Siemens Healthineers AG's quarterly Ending Cash Position
declined
from Dec. 2025 (€2,143 Mil) to Mar. 2026 (€1,908 Mil) but then
increased
from Mar. 2026 (€1,908 Mil) to Jun. 2026 (€2,360 Mil).
Siemens Healthineers AG's annual Ending Cash Position
increased
from Sep. 2023 (€2,247 Mil) to Sep. 2024 (€2,683 Mil) but then
declined
from Sep. 2024 (€2,683 Mil) to Sep. 2025 (€2,175 Mil).
Siemens Healthineers AG Ending Cash Position Related Terms
Siemens Healthineers AG Ending Cash Position Historical Data
* Premium members only.
The historical data trend for Siemens Healthineers AG's Ending Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siemens Healthineers AG Ending Cash Position Chart
Siemens Healthineers AG Ending Cash Position Calculation
Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.
Siemens Healthineers AG's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as
What does a Ending Cash Position of €2,360 Mil mean?
Siemens Healthineers AG (LTS:0PMJ) has a Ending Cash Position of €2,360 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Siemens Healthineers AG and its competitors.
Is Siemens Healthineers AG's Ending Cash Position too high?
Siemens Healthineers AG's current Ending Cash Position is €2,360 Mil. Overall, Siemens Healthineers AG has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's Ending Cash Position compare to ABT and SYK?
Siemens Healthineers AG's Ending Cash Position of €2,360 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Siemens Healthineers AG and its competitors. Siemens Healthineers AG's current Ending Cash Position is €2,360 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (LTS:0PMJ) is currently considered Modestly Undervalued. The stock's GF Value™ is €50.59, compared to a current price of €39.58 — trading 21.8% below its estimated fair value. The current Ending Cash Position is €2,360 Mil. Siemens Healthineers AG's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Siemens Healthineers AG (LTS:0PMJ), the current Ending Cash Position is €2,360 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siemens Healthineers AG (LTS:0PMJ) Overvalued in 2026?
Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued.
The current stock price of €39.58 is trading 21.8% below its estimated GF Value™ of €50.59.
GuruFocus considers Siemens Healthineers AG to be Modestly Undervalued.
Key valuation signals for LTS:0PMJ:
Ending Cash Position: €2,360 Mil
GF Value™: €50.59 vs. price of €39.58 (21.8% below fair value)
No single metric tells the full story. See the LTS:0PMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
81GF Score
Get the complete analysis for LTS:0PMJ
Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0PMJ has been successfully added to your 
